The Oxford University recently announced that it would be partnering with Oracle in order to bring its Scalable Pathogen Pipeline Platform (SP3) to the cloud. By doing so, Oxford aims to be able to identify COVID-19 variants more quickly with the Global Pathogen Analysis System (GPAS).
Oxford’s SP3 was developed to create a single web-based platform to collect, process, and analyze pathogen genetic sequences. SP3 records data from public repositories of genome data and uses container technology in order to build workflows able to examine new genome sequences against known pathogens to identify variants.
By using GPAS, however, it will be able to analyze and compare sequence data of SARS-CoV-2, yielding annotated genomic sequences and identifying new variants. Besides, this platform will also increase performance capability via machine learning and enhances security. GPAS will identify variants that may be spreading more rapidly or show resistance to vaccines and other treatments.
Moreover, the platform is free for researchers and non-profits worldwide, and the researchers wish to expand it to all pathogens to inform decision-making on pandemic response strategies worldwide.